Ulisse Biomed S.p.A. (BIT: UBM)
Italy
· Delayed Price · Currency is EUR 0.848
-0.012 (-1.40%)
Nov 18, 2024, 4:07 PM CET
Ulisse Biomed Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | - | - | -1.31 | -0.6 | 0.22 | -1.1 | Upgrade
|
| Depreciation & Amortization | - | - | 0.12 | 0.25 | 0.05 | 0.06 | Upgrade
|
| Other Amortization | - | - | 0.2 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.1 | - | Upgrade
|
| Other Operating Activities | - | - | -0.15 | -0.14 | -0.04 | -0.05 | Upgrade
|
| Change in Accounts Receivable | - | - | 0.1 | 0.14 | -0.37 | -0 | Upgrade
|
| Change in Inventory | - | - | -0.04 | -0.02 | 0.01 | 0.03 | Upgrade
|
| Change in Accounts Payable | - | - | 0 | -0.07 | 0.14 | -0.01 | Upgrade
|
| Change in Other Net Operating Assets | - | - | 0.11 | 0.05 | -0.51 | 0.67 | Upgrade
|
| Operating Cash Flow | - | - | -0.97 | -0.39 | -0.6 | -0.4 | Upgrade
|
| Capital Expenditures | - | - | -0.08 | - | -0 | -0 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.15 | -0.96 | -0.11 | -0.06 | Upgrade
|
| Investment in Securities | - | - | - | - | - | -0.1 | Upgrade
|
| Other Investing Activities | - | - | - | -0 | -0 | - | Upgrade
|
| Investing Cash Flow | - | - | -0.23 | -0.96 | -0.11 | -0.16 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 0 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0 | Upgrade
|
| Total Debt Issued | - | - | - | 0 | - | 0 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0 | - | Upgrade
|
| Total Debt Repaid | - | - | - | - | -0 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | 0 | -0 | 0 | Upgrade
|
| Issuance of Common Stock | - | - | 0 | 6.3 | - | - | Upgrade
|
| Common Dividends Paid | - | - | - | - | -0.02 | - | Upgrade
|
| Financing Cash Flow | - | - | 0 | 6.3 | -0.02 | 0 | Upgrade
|
| Net Cash Flow | - | - | -1.2 | 4.95 | -0.73 | -0.56 | Upgrade
|
| Free Cash Flow | - | - | -1.05 | -0.39 | -0.6 | -0.41 | Upgrade
|
| Free Cash Flow Margin | - | - | -757.58% | -140.77% | -99.52% | -3743.85% | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.13 | -0.05 | - | -0.08 | Upgrade
|
| Cash Income Tax Paid | - | - | -0 | - | - | - | Upgrade
|
| Levered Free Cash Flow | - | - | -0.67 | -1.43 | -0.64 | -0.08 | Upgrade
|
| Unlevered Free Cash Flow | - | - | -0.67 | -1.42 | -0.64 | -0.08 | Upgrade
|
| Change in Net Working Capital | 0.83 | 0.6 | -0.12 | 0.34 | 0.73 | -0.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.